3.81MMarket Cap
LossP/E TTM
Key Figures
0.406Open
0.420High
186.06KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
2.00%Turnover Ratio
0.406Prev. Close
0.398Low
46.70KTurnover
LossP/E Static
-2.56P/B
0.00%Div Yield TTM
-138.29%ROA
7.95052wk High
1.18Volume Ratio
-11.14MNet Profit
9.29MShares
-2.1360EPS TTM
6.09Beta
-1528.79%ROE
0.54552wk Low
5.32%Amplitude
50.67%Gross Margin
3.81MMarket Cap
-1.82Reward/Risk
5.73%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Vivos Therapeutics Inc's fundamentals are relatively weak, and its growth potential is significant.Its valuation is considered fairly valued, ranking 113 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.12.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Vivos Therapeutics Inc's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Vivos Therapeutics Inc Highlights
StrengthsRisks
Vivos Therapeutics Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Vivos Therapeutics Inc
VVOS
3
Zimmer Biomet Holdings Inc
ZBH
31
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Vivos Therapeutics Inc Info
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Ticker SymbolVVOS
CompanyVivos Therapeutics Inc
CEOHuntsman (R. Kirk)
Websitehttps://vivos.com/
Shareholders
FAQs
What is the current price of Vivos Therapeutics Inc (VVOS)?
The current price of Vivos Therapeutics Inc (VVOS) is 0.41.
What is the symbol of Vivos Therapeutics Inc?
The ticker symbol of Vivos Therapeutics Inc is VVOS.
What is the 52-week high of Vivos Therapeutics Inc?
The 52-week high of Vivos Therapeutics Inc is 7.95.
What is the 52-week low of Vivos Therapeutics Inc?
The 52-week low of Vivos Therapeutics Inc is 0.55.
What is the market capitalization of Vivos Therapeutics Inc?
The market capitalization of Vivos Therapeutics Inc is 3.81M.
Is Vivos Therapeutics Inc (VVOS) currently rated as Buy, Hold, or Sell?
According to analysts, Vivos Therapeutics Inc (VVOS) has an overall rating of Buy, with a price target of 2.12.
What is the Earnings Per Share (EPS TTM) of Vivos Therapeutics Inc (VVOS)?
The Earnings Per Share (EPS TTM) of Vivos Therapeutics Inc (VVOS) is -2.06.